{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-000148","form_type":"8-K","ticker":"ACRS","cik":"0001557746","company_name":"Aclaris Therapeutics, Inc.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.985519+00:00","generated_at":"2026-05-28T03:18:53.710003+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Aclaris Therapeutics updates corporate presentation; no material new data disclosed","bullets":["Company posted an updated investor presentation on January 13, 2025.","Presentation content not fully available in this filing for review.","Routine update; no earnings, pipeline, or financial guidance changes announced.","Presentation available on Aclaris website."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-000148","json":"https://secwatch.observer/filing/0001558370-25-000148.json","markdown":"https://secwatch.observer/filing/0001558370-25-000148.md","text":"https://secwatch.observer/filing/0001558370-25-000148.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557746/000155837025000148/0001558370-25-000148-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557746/000155837025000148/acrs-20250113x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:18:53.710003+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}